
Vatsal Biotech Private Limited
About Vatsal Biotech Private Limited
Data last updated:
Vatsal Biotech Private Limited is a private limited company based in Bhilwara, Rajasthan, India, a subsidiary of Suraj Universal Limited. It operates in the biotechnology segment of the life sciences sector. It was incorporated on 04 September 1998 and has been in existence for over 28 years.
The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U17124RJ1998PTC015097.
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹24.97 Lakh. It was formerly known as R. Vimal Syncotex Private Limited. It is led by directors including Tushar Agarwal and Varun Saraogi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at G – 30 – 31 Ambaji Market, Bhilwara, Rajasthan, India.
As per the financials filed for FY 2025, the company reported a revenue of ₹28.19 Cr, a decline of 5% compared to the previous year. For the same year it recorded a net loss of ₹4.21 Cr (net margin -14.9%) and EBITDA of -₹1.75 Cr (EBITDA margin -6.2%). Revenue has declined at a compounded annual rate (CAGR) of 8% over three years and 9% over five years.
Its group structure includes 2 subsidiaries.
As per MCA filings, the company has open charges of ₹20 Lakh on record. Court records list 6 cases involving the company, including 2 filed by the company and 4 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Vatsal Biotech Private Limited's registered office is in Bhilwara, Rajasthan. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressG – 30 – 31 Ambaji Market, Bhilwara, Rajasthan, India
- IndustryLife Sciences, Biotechnology
To see the full contact details of Vatsal Biotech Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Vatsal Biotech Private Limited
FY 2025 filings availableVatsal Biotech Private Limited reported revenue of ₹28.19 Cr (down 5% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 9% over five years, including a 5% fall in the latest year. EBITDA fell 245% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹1.75 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹4.21 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -6.2% | ||||
| Net Profit Margin | -14.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Vatsal Biotech Private Limited, buy the company report.
Board of directors of Vatsal Biotech Private Limited
Vatsal Biotech has 3 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Tushar Agarwal Also directs: Avv Impex LLP, Suraj Dyeing and Printing Limited, Gattani Fin Lease Private Limited and 1 more | Director | 14 Mar 2016 | 10 Years 8 Months | Current |
| Varun Saraogi | Director | 14 Mar 2016 | 10 Years 8 Months | Current |
| Mohitkumar Hari Beria | Director | 24 Aug 2020 | 6 Years 2 Months | Current |
Peer comparison
Vatsal Biotech Private Limited is compared with the 10 companies closest to it by revenue in the Biotechnology industry (Biotechnology), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Omgene Life Sciences Private Limited | ₹30.12 Cr (FY 2025) | 42.0% | Vadodara, Gujarat, India | |||
| Pranaya Life Sciences Private Limited | ₹29.41 Cr (FY 2024) | -40.0% | Hyderabad, Telangana, India | |||
| Pathnsitu Biotechnologies Private Limited | ₹28.97 Cr (FY 2024) | 20.0% | Hyderabad, Telangana, India | |||
| Centre for Cellular and Molecular Platforms | ₹28.51 Cr (FY 2025) | 9.0% | Bangalore, Karnataka, India | |||
| Hylasco Bio-Technology (India) Private Limited | ₹28.41 Cr (FY 2025) | -2.0% | Hyderabad, Telangana, India | |||
| Vatsal Biotech Private Limitedthis company | ₹28.19 Cr (FY 2025) | -₹4.21 Cr | -14.9% | -5.0% | Bhilwara, Rajasthan, India | |
| Avn Oils Private Limited | ₹26.91 Cr (FY 2024) | 67.0% | New Delhi, Delhi, India | |||
| Earth Agro Structures Private Limited | ₹25.19 Cr (FY 2025) | 26.0% | Zirakpur, Punjab, India | |||
| GV Safety Assessment Platform Private Limited | ₹24.49 Cr (FY 2025) | 110.0% | Hyderabad, Telangana, India | |||
| Cellworks Research India Private Limited | ₹23.98 Cr (FY 2024) | 15.0% | Bangalore, Karnataka, India | |||
| Atgc Biotech Private Limited | ₹23.77 Cr (FY 2024) | 58.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Vatsal Biotech Private Limited, buy the company report.
Auditor
Vatsal Biotech Private Limited is audited by B. B. GUPTA & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| B. B. GUPTA & ASSOCIATES | FY 2023 | 004303C |
Shareholding
The shareholding of Vatsal Biotech Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Vatsal Biotech Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Mar 2001 | 90068610 | Canara Bank | ₹20 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
Vatsal Biotech Private Limited has 6 court cases on record: 2 filed by Vatsal Biotech, 4 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 4 | 2 | 0 |
| District courts | 2 | 2 | 0 |
Cases on record (5 of 6)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court | Criminal miscellaneous application | Filed against the company by Reliance Industries Limited | Disposed |
| High Court | Court case (CRLR) | Filed against the company by Reliance Industries Limited Naroda Ms Singhvi, Sunil Beniwal,Ns Charan,Mukul Singhvi,Jitendra Gang | Disposed |
| District court, Ahmedabad, Gujarat | Court case (CS CCC) | Filed against the company by Reliance Industries Ltd., | Disposed |
| High Court | Appeal | Filed by the company against M/S Reliance Ind. Ltd. Andanr | Disposed |
| High Court | Writ petition | Filed by the company against Registrar,Companies, Jaipur | Disposed |
To see the full case history of Vatsal Biotech Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Vatsal Biotech Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Vatsal Biotech has 2 subsidiary companies and 1 associated company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares held |
|---|---|---|
| Shree Suraj Sponge Iron Private Limited | U17100RJ2009PTC029066 | |
| Gomur Fabrics Private Limited | U17124RJ1987PTC003927 |
To see the full group structure of Vatsal Biotech Private Limited, buy the company report.
GST
No GST registration is on our record for Vatsal Biotech Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Vatsal Biotech Private Limited has 8 board changes on record since 2008: 3 appointments and 5 cessations. The latest: Mohitkumar Hari Beria ceased to be Additional Director on 17 Nov 2020.
Frequently asked questions
Vatsal Biotech is an active private limited company based in Bhilwara, Rajasthan, India. The company works in biotechnology, within the life sciences industry. It was incorporated on 04 September 1998 (28+ years old) and is registered under CIN U17124RJ1998PTC015097.
Vatsal Biotech has 3 current directors:
- Tushar Agarwal - Director
- Varun Saraogi - Director
- Mohitkumar Hari Beria - Director
The latest financial statements of Vatsal Biotech on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Vatsal Biotech is U17124RJ1998PTC015097. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Vatsal Biotech has 6 court cases on record: 2 filed by the company and 4 filed against it. Most are in the high courts.
Vatsal Biotech was incorporated on 04 September 1998, making it 28+ years old. It is registered with the Registrar of Companies, Jaipur.
The peers of Vatsal Biotech by revenue are Omgene Life Sciences Private Limited, Pranaya Life Sciences Private Limited, Pathnsitu Biotechnologies Private Limited, Centre for Cellular and Molecular Platforms, Hylasco Bio-Technology (India) Private Limited and 5 more, all in the Biotechnology industry (Biotechnology).
Mohitkumar Hari Beria ceased to be Additional Director on 17 Nov 2020. Mohitkumar Hari Beria was appointed as Director on 24 Aug 2020. Gopal Chand Agarwal ceased to be Director on 15 Mar 2016. Vatsal Biotech has 8 board changes on record in total.
The registered office of Vatsal Biotech is at G – 30 – 31 Ambaji Market, Bhilwara, Rajasthan, India.
Vatsal Biotech operates in the life sciences industry, in the biotechnology segment.
Vatsal Biotech has open charges of ₹20 Lakh and no satisfied charges on record as per latest MCA filings.

